This drug has two hundred and thirty-six patent family members in twenty-seven countries.
The generic ingredient in XULTOPHY 100/3.6 is insulin degludec; liraglutide. One supplier is listed for this compound. Additional details are available on the insulin degludec; liraglutide profile page.
Copyright © DrugPatentWatch. Originally published at New patent for Novo Nordisk drug XULTOPHY 100/3.6